Cardiovascular Disease

ADHD Meds & Cardiovascular Disease

A meta-analysis of nearly 4M participants found no association between the use of medications to treat ADHD and any cardiovascular disease outcome. 

ADHD medications are known to increase heart rate and blood pressure, and as the use of ADHD medication increases in both adults and children, there has been understandable concern that ADHD meds may lead to adverse cardiovascular effects. 

But these findings suggest these medications may actually be safe for the heart. 

In the systematic review and meta-analysis, researchers analyzed 19 studies from the US, Spain, Denmark, Hong Kong, Canada, and South Korea, involving 3.9M children, adolescents, and adults. 

Researchers found no statistically significant association between ADHD and any CVD outcome among…

  • Children and adolescents (pooled adjusted relative risk: 1.18)
  • Young or middle-aged adults (RR: 1.04)
  • Older adults (RR: 1.59)

Both stimulants and non-stimulants showed no association. When the authors looked at specific cardiovascular outcomes (such as cardiac arrest, arrhythmias, cerebrovascular diseases, or myocardial infarction) there was still no association. There was even no association among those with preexisting CVD.  

The Takeaway

Overall, the findings are reassuring and suggest these medications — which have raised concerns about CVD risk — may be safe for the heart. While the authors acknowledge that a “modest risk increase could not be ruled out,” the findings should comfort readers with cardiovascular patients being treated for ADHD.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Surgeries & Interventions December 11, 2025

CAD and Treating it With PCI has No Impact on TAVR December 11, 2025

New post-hoc results from SCOPE I suggest that patients who have obstructive coronary artery disease as well as symptomatic severe aortic stenosis have similar outcomes to patients without CAD three years after TAVR. The study also suggests performing PCI in parallel to TAVR provides no benefit to these patients. But does the presence of CAD […]

Cardiac Imaging May 4, 2000

CathWorks FFRangio Goes Beyond Physiology May 4, 2000

Despite society guidelines and extensive clinical evidence demonstrating that traditional wire-based coronary physiology improves outcomes and reduces costs compared to angiography alone1-2, physiology continues to be disappointingly underutilized globally due to the inconvenience and time it adds to the procedure. The novel CathWorks FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic […]

Obesity Care December 8, 2025

Childhood Obesity CHD Risks Might Be Reversible December 8, 2025

Childhood obesity’s cardiovascular consequences might be reversible with timely intervention, after a Swedish study demonstrated that children who were overweight but achieved normal weight by young adulthood had similar coronary heart disease risk to their “never-overweight” peers. The BMI Epidemiology Study analysis linked health records to nationwide registries for 103k people in Sweden to track […]